NEW YORK (GenomeWeb News) – Genomatix Software said today that Pfizer has licensed use of its software and databases for use by Pfizer Pharmaceuticals’ sites around the world.
 
The Munich, Germany-based bioinformatics company said that Pfizer will use the software and data content “to help understand the molecular basis of how their potential drug targets may be co-regulated with other important targets, producing potential desirable or unwanted side effects.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.